What Is an Alarmone and What Does It Do?

An alarmone is a small signaling molecule that a cell produces in response to stress, and it rapidly reshapes the cell’s behavior to improve its chances of survival. The most studied alarmones are guanosine tetraphosphate and guanosine pentaphosphate, collectively written as (p)ppGpp and sometimes called “magic spots” after the mysterious spots researchers first noticed on chromatography plates decades ago. When a bacterium runs low on nutrients or faces other harsh conditions, (p)ppGpp accumulates and acts as a master switch, dialing down growth-related processes and dialing up stress-survival programs. The story turns out to be richer than a simple on-off switch, though, because alarmones touch nearly every major function a bacterial cell performs.

How Bacteria Detect Trouble

The classic trigger for alarmone production is amino acid starvation. When a bacterium cannot find enough amino acids to keep building proteins, its transfer RNA molecules (tRNAs, the adaptors that carry amino acids to the ribosome) show up empty. In the well-studied bacterium E. coli, an enzyme called RelA rides on the ribosome and detects these uncharged tRNAs when they land at the ribosome’s decoding site. That event flips RelA into its active state, and it begins cranking out (p)ppGpp. Structural work has shown that RelA’s ability to bind tRNA, its ability to bind the ribosome, and its ability to synthesize (p)ppGpp are all interdependent: disrupt one, and you disrupt them all.¹ This tight coupling ensures that alarmone production only fires when amino acid shortage is genuinely affecting the ribosome, not just fluctuating in the surrounding broth.

Amino acid starvation is the textbook example, but it is not the only trigger. Broader nutrient deprivation, fatty acid limitation, and other environmental stresses can also drive (p)ppGpp levels up, depending on the species. The overall response, known as the stringent response, represents one of the most widespread and ancient stress-survival strategies in bacteria.²

The Enzymes That Build and Destroy Alarmones

The levels of (p)ppGpp inside a cell are controlled by a family of enzymes called RSH proteins, short for RelA-SpoT Homologs. These come in three broad flavors. “Long” RSH proteins carry both a synthesis domain (for making the alarmone) and a hydrolysis domain (for breaking it down), often with additional regulatory regions. “Small alarmone synthetases” carry only the synthesis domain, and “small alarmone hydrolases” carry only the breakdown domain. Across the tree of life, researchers have cataloged roughly 30 distinct subgroups within these three classes, reflecting the enormous evolutionary diversification of this signaling system.³

In E. coli, the labor is split between two long RSH proteins. RelA is the primary synthetase, activated at the ribosome during starvation. SpoT handles most of the breakdown but can also synthesize (p)ppGpp under certain conditions. Many other bacteria carry a single bifunctional long RSH called Rel that does both jobs. On top of these, some species have small alarmone synthetases like RelP and RelQ, which form compact homotetramers and can fine-tune alarmone levels independently of the ribosome.⁴ The result is a layered control system: coarse adjustments via the main RSH enzymes, plus additional fine-grained inputs from the smaller ones.

Rewiring Transcription

Once (p)ppGpp accumulates, one of its most dramatic effects is on gene expression. In E. coli, ppGpp binds directly to RNA polymerase, the enzyme responsible for reading DNA and producing messenger RNA. Crystal structures show that ppGpp attaches to a spot on the outer surface of RNA polymerase, bridging two movable modules and restricting how the enzyme’s active cleft opens and closes. This slows down the enzyme’s ability to start new transcripts and destabilizes the initial complexes that form at gene promoters.⁵

That alone would be a blunt instrument, slowing everything equally. But bacteria sharpen the effect with a helper protein called DksA. Researchers discovered that ppGpp actually binds RNA polymerase at two distinct sites roughly 60 angstroms apart. The second site sits at the interface between RNA polymerase and DksA, and this is where the real regulatory magic happens. Binding at site 2 accounts for most of ppGpp’s effects on which genes get turned on or off, and bacteria engineered to lack site 2 struggle severely when nutrients shift.⁶ When ppGpp occupies this second site, DksA undergoes a subtle rotation that repositions its tip deep into RNA polymerase’s active channel, directly interfering with the next nucleotide trying to be added to a growing RNA chain.⁷

The net effect is selective: genes for ribosomal RNA and other growth machinery get suppressed, while genes for amino acid biosynthesis and stress survival often get activated. A genome-wide study of the stringent response during amino acid starvation in E. coli confirmed that the cell comprehensively restructures its metabolic gene expression and turns on its general stress defenses, while downregulating genes for building large cellular structures.⁸

Hitting the Brakes on Protein Synthesis and DNA Replication

Transcription is not the only target. Alarmones also directly interfere with the machinery that translates messenger RNA into protein. ppGpp binds to Initiation Factor 2 (IF2), an essential protein that helps the ribosome begin reading a new message. ppGpp occupies the same binding pocket as GTP, the molecule IF2 normally uses as fuel, and in doing so prevents IF2 from being activated properly. The result is that new rounds of protein synthesis stall at their very first step.⁹ Biophysical measurements show that ppGpp actually binds IF2 with higher affinity than it binds Elongation Factor G, another translational GTPase, suggesting that shutting down translation initiation is the priority during stress.¹⁰

DNA replication gets a similar treatment. During the stringent response, new rounds of chromosome replication are blocked. The mechanism is indirect but elegant: ppGpp suppresses transcription globally, and active transcription normally introduces the local DNA unwinding near the origin of replication that helps kick off a new replication cycle. Remove the transcription, and the origin stays wound too tightly to fire.¹¹ Meanwhile, ppGpp also directly inhibits enzymes involved in making the nucleotide building blocks that DNA and RNA require, further starving the replication and transcription machinery of raw materials.¹²

Biofilms, Persistence, and Antibiotic Tolerance

The practical consequences of all this metabolic reprogramming extend well beyond lab curiosities. One of the most medically relevant effects of alarmone signaling is the formation of persister cells: dormant bacterial cells that are not genetically resistant to antibiotics but tolerate them by essentially shutting down the processes that antibiotics target. When (p)ppGpp accumulates, it drives cells into a slow-growing or non-growing state, making them invisible to drugs that need active growth to kill.¹³ Even basal levels of ppGpp in non-stressed cells contribute to the natural heterogeneity within a bacterial population, meaning a small fraction of cells are always primed for persistence.

Alarmones also promote biofilm formation, the structured communities of bacteria encased in a self-produced matrix that are notoriously difficult to treat with antibiotics. In Pseudomonas aeruginosa, a pathogen responsible for chronic lung infections and wound infections, increasing (p)ppGpp concentrations led to progressively denser biofilms across multiple strains.¹⁴ The relationship between alarmones and biofilms is not identical across all species, though. In Pseudomonas putida, deleting the genes for (p)ppGpp synthesis actually increased biofilm formation on plastic surfaces while weakening the structure of floating biofilms at the air-liquid interface, highlighting that the alarmone’s role in biofilm regulation depends heavily on species and context.¹⁵

Virulence in Pathogens

For disease-causing bacteria, alarmones serve as coordinators of virulence. The logic makes sense: a pathogen landing on or inside a host often faces nutrient scarcity and immune assault, exactly the conditions that spike (p)ppGpp levels. In Salmonella Typhi, the bacterium behind typhoid fever, strains engineered to produce no (p)ppGpp showed dramatically reduced ability to invade intestinal cells, survive inside immune cells, and spread systemically. In a mouse infection model, the alarmone-deficient strain caused no deaths, compared to complete lethality for the normal strain.¹⁶

Similar findings emerge in plant pathogens. Pseudomonas syringae, which causes bacterial speck disease in crops, completely lost its ability to cause disease on bean plants when its alarmone-producing genes were knocked out. Expression of its type III secretion system, a molecular syringe used to inject toxins into plant cells, dropped sharply without (p)ppGpp.¹⁷ In Clavibacter michiganensis, a devastating tomato pathogen, researchers found that (p)ppGpp controls virulence through a dual mechanism, regulating both the production and the secretion of the enzymes the bacterium uses to chew through plant cell walls.¹⁸

Triggering Antibiotic Production in Soil Bacteria

Not all consequences of alarmone signaling are about surviving danger in the moment. In Streptomyces, the soil-dwelling bacteria responsible for producing the majority of naturally occurring antibiotics used in medicine, (p)ppGpp plays a developmental role. When ppGpp levels rise, Streptomyces coelicolor activates the gene clusters responsible for making antibiotics like actinorhodin and calcium-dependent antibiotic (CDA), while simultaneously repressing genes associated with active growth.¹⁹ Mutants unable to produce ppGpp fail to make these antibiotics under nitrogen-limited conditions and show a conspicuous delay in forming the aerial structures that eventually become spores.²⁰ In other words, (p)ppGpp tells the bacterium that times are tough and it should shift from growing into weaponizing its environment and preparing for long-term dormancy as spores.

Beyond (p)ppGpp: Other Molecules Called Alarmones

While (p)ppGpp dominates the conversation, it is not the only molecule that has earned the “alarmone” label. In the 1980s, researchers studying Salmonella and E. coli discovered that heat shock and exposure to oxidizing chemicals triggered the rapid accumulation of a chemically distinct family of molecules: adenylylated dinucleotides, especially diadenosine tetraphosphate (AppppA). These molecules pile up specifically in response to oxidative stress and heat, but not other types of stress.²¹ Their synthesis appears to be linked to aminoacyl-tRNA synthetases under oxidative conditions, though the process is not simply a side effect of those enzymes being inhibited.

The researchers who characterized these molecules proposed that AppppA and its relatives are alarmones that signal the onset of oxidative damage, and that different members of the family might even flag specific types of oxidative injury.²² AppppA has been found to bind several well-known stress proteins, including the chaperones DnaK and GroEL, and this accumulation under stress has been observed across all cell types examined.²³ The oxidative-stress alarmones remain less thoroughly understood than (p)ppGpp, but they expand the concept of alarmone signaling beyond starvation into a broader principle: cells synthesize specific small molecules to flag specific categories of danger.

Bacteria also use cyclic dinucleotides like c-di-GMP and c-di-AMP as second messengers, and these are sometimes discussed alongside (p)ppGpp because they interact with overlapping cellular processes. There is genuine cross-talk between these signaling pathways, though cyclic dinucleotides regulate a somewhat different set of behaviors, including motility-to-biofilm transitions and cell-wall homeostasis.²⁴

Alarmones in Plants and Chloroplasts

One of the more surprising aspects of alarmone biology is that (p)ppGpp signaling is not confined to bacteria. Plants and algae also produce (p)ppGpp, using their own RSH enzymes. These enzymes are encoded in the nuclear genome but function inside chloroplasts, the organelles descended from ancient cyanobacteria that handle photosynthesis. Inside chloroplasts, (p)ppGpp reduces transcription and translation, affects lipid and hormone levels, and influences photosynthetic efficiency and overall plant growth.²⁵ Recent work positions (p)ppGpp as a conserved regulator of photosynthetic activity, helping plants and algae acclimate to environmental stress by throttling chloroplast output when conditions deteriorate.²⁶ The fact that this signaling system survived billions of years of evolution, from free-living cyanobacteria through the endosymbiotic origin of chloroplasts to modern crop plants, speaks to how fundamental alarmone-based stress management really is.

Alarmone Synthetases as Drug Targets

The deep involvement of (p)ppGpp in persistence and virulence has made the enzymes that produce it attractive targets for new antibiotics. The reasoning is straightforward: conventional antibiotics generally kill actively growing bacteria, but persister cells with a slowed metabolism survive treatment and can later reseed an infection. If you could block alarmone production, you might prevent bacteria from entering that protected dormant state in the first place.²⁷

Several compounds are in early-stage development along these lines. One promising lead is DMNP, a synthetic analog of erogorgiaene, a compound originally found in marine coral. DMNP targets multiple (p)ppGpp synthetases and inhibits their activity, disrupting persister cell formation and eradicating biofilms in mycobacteria.²⁸ This class of compounds, which also includes an earlier molecule called relacin, represents a fundamentally different strategy from traditional antibiotics. Rather than trying to kill bacteria directly, alarmone synthetase inhibitors aim to strip bacteria of their stress defenses, potentially making them vulnerable to the immune system or to conventional drugs used in combination.²⁹

There is an ironic flip side to this strategy worth noting. At least one compound that inhibits aminoacyl-tRNA synthetases, an antibiotic called AN3365 originally developed against Gram-negative infections, was found to cause dramatic accumulation of (p)ppGpp as a side effect of blocking tRNA charging. In other words, the very drug meant to kill bacteria was inadvertently triggering the alarmone-driven tolerance pathway, potentially undermining its own effectiveness.³⁰ This kind of unintended consequence underscores why understanding alarmone biology is not purely academic: it has real implications for how we design antibiotic strategies and why some treatments fail against chronic or relapsing infections.